Mobile Menu
Deals & Transactions

Conyers advises Jazz Investments on Listing of Senior Notes on Bermuda Stock Exchange

October 2017

Conyers advised Jazz Investments I Limited, a Bermuda company and a wholly-owned subsidiary of Jazz Pharmaceuticals plc, on the listing on the Bermuda Stock Exchange of US$575,000,000 1.50% Exchangeable Senior Notes due 2024 of Jazz Investments I Limited.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs.

David J. Doyle, Kathleen Moniz and Kent Smith of Conyers’ Bermuda office worked on the matter working alongside Cooleys (San Diego) and A L Goodbody (Dublin & London).



"I enjoy working with them - they are very dependable, reliable and responsive."
- Chambers Global